• Rare and Inherited Retinal Diseases

    Do our genes hold the cure?

    Read Issue
  • Business Matters

    Protect Your Assets

    Read Article
  • Topcon Swept Source OCT and Uveitis

    Swept Source OCT offers several advantages over spectral domain OCT.

    Read Article
  • SubLiminal Laser Therapy for Central Serous Chorioretinopathy

    Finding an Effective Treatment Option With No Side Effects

    Read Article
  • Automated Fundus Photography:

    Implications for Clinical Practice and Telemedicine

    Read Article
  •  
     
  • Retinal Disease Awareness News
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • diabetes awareness month
  • wet age-related macular degeneration month
  • Articles From This Issue

     

    UP FRONT

    Medical Editors’ Page

    An Era of Customized Retina Care

    Four Favorites Retina Today’s choice takeaways from this issue. 1 “Approximately half of those requiring surgical intervention to reverse the condition in on…

    Medical Update

    The “C” Word HIGHER VITAMIN D LEVELS LINKED TO LOWER COLORECTAL CANCER RISK Higher levels of vitamin D are associated with a lower risk of colorectal cancer, acco…

    Retina News

    Aflibercept Label Now Includes 12-Week Dosing Interval for AMD The US FDA in August approved an updated label for aflibercept (Eylea, Regeneron), adding every-12-week injection …

     

    Supplements and Inserts

    Insert

    Topcon Swept Source OCT and Uveitis

    NEWS


     

    Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results

    Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for us…

    GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)

    GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sham-treated eyes demonstra…

    Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes

    A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endothelial growth factor (VEGF) i…

    Patients Regain Sight After Being First to Get Retinal Tissue Engineered From Stem Cells

    The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision, according to a report in VisionMonday. Th…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman
    Editor-in-Chief
    484-581-1827
    kroman@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.